Results 51 to 60 of about 202,498,393 (134)

Treatment for congenital toxoplasmosis: finding out what works [PDF]

open access: yes, 2009
Evidence for the effectiveness of prenatal or postnatal treatment for congenital toxoplasmosis will be critical to guide policy about prenatal and neonatal screening over the next 10 years, let alone the next 100.
Gilbert, R, Ruth Gilbert
core   +1 more source

Genetic counseling for congenital disorders of glycosylation (CDG)

open access: yesJournal of Genetic Counseling, Volume 33, Issue 6, Page 1358-1364, December 2024.
Abstract Congenital disorders of glycosylation (CDGs) are a genetically and clinically diverse group of disorders that arise as a result of defects within glycosylation synthetic pathways. CDGs are caused by pathogenic variants in many different genes in the glycosylation network.
Tara Weixel   +2 more
wiley   +1 more source

Prenatal diagnosis of a 15q24.1 microdeletion in a fetus with cerebral and urogenital abnormalities

open access: yesClinical Genetics, Volume 106, Issue 5, Page 537-544, November 2024.
15q24.1 microdeletion syndrome is a rare condition, rarely diagnosed before birth. We give new insights into prenatal malformations and candidate genes involved in embryogenesis. Such malformations on ultrasound scan, may lead to prenatal genetic testing. Abstract 15q24.1 microdeletion syndrome is a recently described condition often resulting from non‐
Anaïk Previdi   +8 more
wiley   +1 more source

Discovering the Hidden Power of NGLY1: Orchestrating Immune Cell Functions and Autoimmune Diseases

open access: yesFrontiers in Bioscience-Landmark
The enzyme N-glycanase 1 (NGLY1) regulates autophagic processes and endoplasmic reticulum (ER)-associated proteasomal degradation by de-N-glycosylation of misfolded glycoproteins.
Christina B. Brunner   +6 more
doaj   +1 more source

Autosomal Recessive Dilated Cardiomyopathy due to DOLK Mutations Results from Abnormal Dystroglycan O-Mannosylation [PDF]

open access: yes, 2011
Genetic causes for autosomal recessive forms of dilated cardiomyopathy (DCM) are only rarely identified, although they are thought to contribute considerably to sudden cardiac death and heart failure, especially in young children.
van Reeuwijk, Jeroen   +100 more
core   +2 more sources

Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies

open access: yesMedComm, Volume 5, Issue 10, October 2024.
Posttranslational modifications of proteins are involved in the development of metabolism‐related diseases such as diabetes mellitus, obesity, hyperlipidemia, and nonalcoholic fatty liver disease. PTMs mediates the development of diabetes mellitus by affecting insulin homeostasis, glucose metabolism, diabetic complications, gluconeogenesis, and β‐cell ...
Yunuo Yang   +4 more
wiley   +1 more source

Dysregulated proteome and N‐glycoproteome in ALG1‐deficient fibroblasts

open access: yesPROTEOMICS, Volume 24, Issue 15, August 2024.
Abstract Asparagine‐linked glycosylation 1 protein is a β‐1,4‐mannosyltransferase, is encoded by the ALG1 gene, which catalyzes the first step of mannosylation in N‐glycosylation. Pathogenic variants in ALG1 cause a rare autosomal recessive disorder termed as ALG1‐CDG.
Rohit Budhraja   +5 more
wiley   +1 more source

Impaired myoblast differentiation and muscle IGF‐1 receptor signaling pathway activation after N‐glycosylation inhibition

open access: yesThe FASEB Journal, Volume 38, Issue 13, 15 July 2024.
N‐glycosylation inhibitions by Tunicamycin (TUN) or by knockdown of phosphomannomutase 2 (PMM2) gene block the C2C12 myoblast fusion and impair the myogenic program. TUN treatment decreased myogenic markers and increased atrophy markers in muscles of WT and MLC/mIgf‐1 mice, which overexpress muscle Igf‐1Ea mRNA isoform.
Giosuè Annibalini   +13 more
wiley   +1 more source

Congenital Hypoplasia of Carpal Scaphoid Bone [PDF]

open access: yes, 2003
Congenital hypoplasia or aplasia of carpal scaphoid bone without other abnormality is a rare disorder.
강호정   +3 more
core  

Congenital disorders of glycosylation with multiorgan disruption and immune dysregulation caused by compound heterozygous variants in MAN2B2

open access: yesMolecular Genetics &Genomic Medicine, Volume 12, Issue 4, April 2024.
Congenital disorders of glycosylation with novel phenotypes and disruptive N‐glycan profiling caused by compound heterozygous MAN2B2 variants (NM_015274.1, c.384G>T; c.926T>A). Abstract Background Congenital disorders of glycosylation (CDG) are a type of inborn error of metabolism (IEM) resulting from defects in glycan synthesis or failed attachment of
Shiqi Fan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy